Market Place
Sourcing Support
invIOs Raises €8.2 Million In Series A For Immuno-Oncology
15 Oct 2024 //
GLOBENEWSWIRE
eFFECTOR, Dana-Farber To Study Zotatifin ER+ Endo/Ovarian Cancer Combo
20 May 2024 //
GLOBENEWSWIRE
Dana-Farber’s computer platform makes patient matching process easier
14 Oct 2022 //
CLINICALTRIALSARENA
Dana-Farber CEO Laurie Glimcher resigns from GSK board
29 Jul 2022 //
ENDPTS
Novel cancer vaccines look beyond T cells to better fight tumors
27 May 2022 //
FIERCEBIOTECH
Varsity Pharmaceuticals Licenses Pol-Theta Inhibitor
07 Feb 2022 //
BUSINESSWIRE
BAKX nets more cash for its `Thelma and Louise` approach to cancer cell death
18 Nov 2021 //
ENDPTS
Eureka Initiates Phase I/II ARYA-2 Trial of ET140203 ARTEMIS T Cells
17 Nov 2021 //
BUSINESSWIRE
Lew Cantley is headed to Dana-Farber
11 Nov 2021 //
ENDPTS
Renowned Dana-Farber scientist, David Livingston has died
20 Oct 2021 //
ENDPTS
Luba Greenwood takes the helm at Kojin Therapeutics; Alexion R&D chief packs up
15 Oct 2021 //
ENDPTS
Kojin Therapeutics Announces Luba Greenwood as Chief Executive Officer
14 Oct 2021 //
BUSINESSWIRE
Biotech backers quit Dana-Farber board after policy U-turn
13 Oct 2021 //
FIERCEBIOTECH
C4 co-founder resigns as Dana-Farber trustee — report
11 Oct 2021 //
ENDPTS
Biden`s choice for FDA may be a wild card
07 Oct 2021 //
ENDPTS
AstraZeneca taps Dana-Farber`s Rahma to lead its GI work
17 Sep 2021 //
FIERCEBIOTECH
Lucence`s Liquid Biopsy Detects Actionable Genomic Alterations in Bladder Cancer
13 Sep 2021 //
BUSINESSWIRE
SpringWorks & Leading Cancer Institute collaborate to Evaluate Nirogacestat
30 Aug 2021 //
GLOBENEWSWIRE
Copyright © 2024 LePro PharmaCompass OPC Private Limited, All rights reserved.